SCHEMBL653675

SCHEMBL653675

COc1cc(N2C[C@@]3(Cc4ccccc4)CN(C(=O)O)C[C@@H]23)cnc1Br

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 8/20 0.41
CHRNA4 P43681 8/20 0.41
CHRNB4 P30926 7/20 0.41
CHRNA3 P32297 7/20 0.41
GRIN2B Q13224 3/20 0.35
APP P05067 2/20 0.34
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
ALK Q9UM73 1/20 0.33
ALDH1A1 P00352 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
MAPK14 Q16539 1/20 0.33
DRD2 P14416 2/20 0.33
DRD4 P21917 2/20 0.33
DRD3 P35462 2/20 0.33
MAPT P10636 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL929834 0.83 CHRNB2 (0.41) CHRNB2CHRNA4CHRNB4CHRNA3ALDH1A1
SCHEMBL652629 0.83 CHRNB2 (0.43) CHRNB2CHRNA4CHRNB4CHRNA3GRIN2B
SCHEMBL653615 0.81 SMN1; SMN2 (0.37) CHRNB2CHRNA4CHRNB4CHRNA3GRIN2B
SCHEMBL650794 0.81 SMN1; SMN2 (0.37) CHRNB2CHRNA4CHRNB4CHRNA3GRIN2B
SCHEMBL652521 0.80 CHRNB2 (0.42) CHRNB2CHRNA4CHRNB4CHRNA3GRIN2B
SCHEMBL654460 0.80 MEN1 (0.44) CHRNB2CHRNA4CHRNB4CHRNA3GRIN2B
SCHEMBL649307 0.77 GRIN2B (0.42) CHRNB2CHRNA4CHRNB4CHRNA3GRIN2B
SCHEMBL653486 0.77 GRIN2B (0.42) CHRNB2CHRNA4CHRNB4CHRNA3GRIN2B
SCHEMBL651858 0.75 ARG1 (0.39) CHRNB2CHRNA4CHRNB4CHRNA3GRIN2B
SCHEMBL651156 0.75 ARG1 (0.39) CHRNB2CHRNA4CHRNB4CHRNA3GRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119635-B2 Diazabicyclic central nervous system active agents ABBOTT LABORATORIES (US) 2012-02-21 US disclosed
EP-2298775-A1 Diazabicyclic central nervous system active agents Abbott Laboratories (US) 2011-03-23 EP disclosed
EP-2295437-A1 Diazabicyclic central nervous system active agents Abbott Laboratories (US) 2011-03-16 EP disclosed